RVL Pharmaceuticals PLC (OTCPK:RVLPQ)
$ 0.0001 0 (0%) Market Cap: 11,000.00 Enterprise Value: 39.00 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2019 Osmotica Pharmaceuticals PLC Earnings Call Transcript

Nov 15, 2019 / 01:30PM GMT
Release Date Price: $4.12 (+2.49%)
Operator

Ladies and gentlemen, thank you for standing by. And welcome to the Osmotica Third Quarter 2019 Earnings Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Lisa Wilson, Investor Relations at Osmotica Pharmaceuticals. Please go ahead, ma'am.

Lisa Wilson;In;Site Communications;Founder and President

Thank you, operator. Welcome to Osmotica Pharmaceuticals Third Quarter 2019 Business Update Call. This is Lisa Wilson, Investor Relations for Osmotica. With me on today's call are Osmotica's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andrew Einhorn.

The company issued a press release detailing financial results for the 3 months ended September 30, 2019, yesterday after the close of market.

This press release and a webcast of this call can be accessed through the Investors section of the Osmotica website at osmotica.com. Before we get started, I would like to remind everyone that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot